CBD works in a number of ways to reduce the cytokine storm for patients of COVID-19. And, one way is to reduce is to increase levels of a natural peptide called apelin – known to reduce inflammation.
In a study carried out by researchers at Medical College of Georgia and dental College of Georgia, the ability of CBD to improve oxygen level and reduce inflammation reported. The ability of CBD to reduce physical lung damage in the laboratory model of deadly adult respiratory distress syndrome (ARDS) reported as well.
Besides this, the study shows that apelin levels drop down with viral infection. In such a situations, CBD quickly helps normalize apelin level along with lung function. Meanwhile, amidst the COVID-19 pandemic, worldwide, 1 million people have succumbed to the infection.
Study shows linear relationship between apelin and CBD
“CBD works dramatic in both directions, i.e. shifting apelin levels in both lung tissue and circulating blood. In the ARDS model, blood levels of peptide reduced close to zero and increased 20 times with CBD. The finding is reported in the Journal of Cellular and Molecular Medicine.
With this, CBD peptide level changed almost to a normal, pointing out the apparent first connection between apelin and CBD.
A pervasive peptide, apelin is synthesized by the cells in the lung, heart, brain, fat tissue, and blood, and is an important regulator to bring down both blood pressure and inflammation.
For example, if the blood pressure gets high, apelin should up in the right place, such as in the endothelial cells that line blood cells, to help it bring down. Meanwhile, apelin needs to do the same to normalize significant increase in inflammation of the lungs, and breathing difficulties related with ARDS.